Tags: Digestive Problems | colitis | nestle | drug

Colitis Relief: New Treatment Promotes Healing

Image: Colitis Relief: New Treatment Promotes Healing
(Copyright AP)

Wednesday, 16 Sep 2015 11:19 AM

Nestle is working with Lipid Therapeutics to develop and commercialize a new therapeutic treatment for mild-to-moderate ulcerative colitis, which can causes ulcers, bleeding and pain due to inflammation of the colon, the company said on Wednesday.

Nestle Health Science intends to develop an add-on therapy to an existing one that is commonly used but with which 40 percent of patients continue to experience flare-ups, the company said.

The LT-02 compound under development by Nestle can help to heal ulcers and restore lining of the colon wall, reducing chances of the condition returning.

The agreement is part of Nestle Health Science’s strategy to develop its product portfolio for gastrointestinal diseases, it said.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Nestle is working with Lipid Therapeutics to develop and commercialize a new therapeutic treatment for mild-to-moderate ulcerative colitis, which can causes ulcers, bleeding and pain due to inflammation of the colon, the company said on Wednesday. Nestle Health Science...
colitis, nestle, drug
111
2015-19-16
Wednesday, 16 Sep 2015 11:19 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved